General Proximity · May 2026
FreeMind Investments announced an investment in General Proximity; the company said it has raised over $20M, received non-dilutive grants, and continues advancing OmniTAC programs.
The next generation of induced-proximity medicines.
Company research
Public company, workplace, funding, and market signals
Overview
General Proximity is a San Francisco biotech startup building OmniTAC, a mechanism-agnostic induced-proximity discovery platform that scans the effectome to create drug candidates for previously undruggable targets.
Primary product
OmniTAC induced-proximity discovery platform
Founded
2019
Headquarters
San Francisco, California, United States
Team size
11-50
Work style
Onsite
Industry
Biotechnology
Sub-industry
Induced proximity medicines / drug discovery platform
Offices
MBC BioLabs, 135 Mississippi Street, San Francisco, CA 94107, United States
Open Positions
9 jobs at General Proximity
Scientist/Sr. Scientist, DMPK
On-siteChemistry TeamSan Francisco, CAToday
On-site